Lv5
1045 积分 2021-07-30 加入
T-Cell Engagers in Solid Tumors: Challenges and Emerging Strategies
14天前
已完结
Anticalins: A viable alternative to nanobodies? –from discovery to AI-driven development: A review
5个月前
已完结
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models
6个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
6个月前
已完结
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement
6个月前
已完结
The Regulation and Modification of GSDMD Signaling in Diseases
11个月前
已完结
皖公网安备34019202002308
